Author： Sehouli Jalid Oskay-Özcelik Gülten
Publisher： Informa Healthcare
ISSN： 1473-4877
Source： Current Medical Research and Opinion, Vol.25, Iss.3, 2009-03, pp. : 639-651
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Future Role of Topotecan in the Treatment of Lung Cancer
Oncology, Vol. 61, Iss. 1, 2001-09 ,pp. :
Access to resources
Recommend
Current and future developments in screening for ovarian cancer
By Urban Nicole Drescher Charles
Women's Health, Vol. 2, Iss. 5, 2006-09 ,pp. :
Topotecan and Gemcitabine in Platinum/Paclitaxel-Resistant Ovarian Cancer
Oncology, Vol. 60, Iss. 1, 2000-12 ,pp. :
First-Line Chemotherapy in Advanced Ovarian Cancer: State of the Art and Future Aspects
Oncology Research and Treatment, Vol. 22, Iss. 4, 1999-09 ,pp. :
Hormonal Therapy with Letrozole for Relapsed Epithelial Ovarian Cancer
Oncology, Vol. 66, Iss. 2, 2004-05 ,pp. :